We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Johnson & Johnson on Monday released its 2016 transparency report, which showed that the list prices of its pharmaceutical products in the US rose by an average of 8.5 percent, compared with the year before.